ENX-102 for the Treatment of Generalized Anxiety Disorder (H-53469)
Description
Content
The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD).
If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation will also be provided for time and travel.
Contact
Phone 1: 713–689–9856
IRB: H-53469
Status:
Active
Created:
